Pharmacy Linguist

About Me

My name is Kaspars Melkis and I am a translator of medical and pharmaceutical texts with more than 25 years of experience. My working languages are English and Latvian, but I also speak Russian and Spanish.

I have experience in the following areas:



Detailed experience:

  • Clinical trial documentation: translation, editing, compliance checking. Informed consent forms, clinical trial manuals, investigator contracts, product information leaflets, investigational drug labels, study protocols, advertisement posters, etc.
  • Regulatory documents: European Medicines Agency (EMA) workflow, Summary of product characteristics (SmPC), Patient information leaflets (PIL), scientific conclusions, application letters, QRD templates.
  • Linguistic debriefing and harmonization projects for clinical studies. PRO, EQ-5D instruments, forward and back translations. Cognitive debriefing: patient interviews by phone and in person, evaluation of linguistic results.
  • Other medical and pharmaceutical products: medical devices, discharge letters, care plans, clinical assessments, tests & investigations, lab manuals, testing plans, pharmacopeia articles, microbiology equipment and procedures.

  • End clients include many pharmaceutical and medical device companies, big and small: Baxter, Abbott Laboratories, AbbView, Actavis, Actelion, Alnylam Pharmaceuticals, Amag Pharmaceuticals, Amgen, aniMedica (a member of LIVISTO), Aquinox Pharmaceuticals, Arena Pharmaceuticals, Aventis Pharma (now Sanofi), Bayer Schering Pharma, Bial, BioMarin Pharmaceutical, BioQ Pharma, Boehringer-Indgelheim, Bristol-Myers Squibb, Cardio3 BioSciences (now Celyad), Celgene, Cempra Pharmaceuticals (now Melinta Therapeutics), Chiesi Farmaceutici S.p.A., Coherus BioSciences, CSL Behring, Daiichi Sankyo, Eli Lilly and Company, EpicentRx, Ferring Pharmaceuticals, Genentech (subsidiary of Roche), Genzyme Europe (subsidiary of Sanofi), Gilead Sciences, Glycomine, Hexal Australia, Hoffmann-La Roche, Horizon Pharma, Immune Tolerance Network, Janseen Pharmaceutical Products, Kite Pharma (now Gilead Sciences), Koninklijke Philips, Kyowa Hakko Kirin, Lipomed, Lundbeck, Mallinckrodt Pharmaceuticals, Melinta Therapeutics, Menarini, Merck & Co., Motif BioSciences, Mylan, Nabriva Therapeutics, Novartis, Novo Nodrisk, Orient Pharma, Orion Pharma, Orphan Europe, Otsuka Pharmaceutical Co., Pfizer, PregLem, Protagonist Therapeutics, Regeneron Pharmaceuticals, Sanofi, Santen Pharmaceutical, Santhera Pharmaceuticals, Seqirus Netherlands, Shire, Shire Plc., Sicor Biotech (Teva group), Takeda Pharmaceutical Co., Teva Pharmaceuticals, Theravance Biopharma Antibiotics, Tillotts Pharma, Toleranzia, UCB, Urovant Sciences, MED-EL, Accuray, Advanced Accelerator Applications, B. Braun Melsungen, bioMerieux, CeloNova BioSciences (now Boston Scientific), Centurion Medical (part of Medline Industries), Fisher & Paykel Healthcare, Hospira UK (now part of Pfizer), Instrumentation Laboratory, Kerr Corporation, Micromedics, Mirador Biomedical (subsidiary of Centurion Medical), Navilyst Medical, Nordson Medical, priMed Medical Products, Scanlan Instrumentation, Siemens Healthcare Diagnostics, St. Jude Medical, Thompson Surgical Instruments, Thoratec.


    I also have proz.com profile and LinkedIn profile and my other website is www.latvianforyou.com.

    E-mail: melkis@avepro.com    Phone: +44 753-575-3131

    © 2017–2018 Kaspars Melkis